期刊簡介 | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | JOURNAL OF ETHNOPHARMACOLOGY LetPub Score 7.6
51 ratings
Rate
Reputation 7.9 Influence 6.8 Speed 8.1 | ||||||||||||||||||||||||||
期刊簡稱 | J ETHNOPHARMACOL | ||||||||||||||||||||||||||
ISSN | 0378-8741 | ||||||||||||||||||||||||||
E-ISSN | 1872-7573 | ||||||||||||||||||||||||||
h-index | 170 | ||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||
自引率 (2023-2024) | 10.40%自引率趨勢 | ||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||
官方網站 | https://www.journals.elsevier.com/journal-of-ethnopharmacology | ||||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/JETHNO | ||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||
出版商 | Elsevier Ireland Ltd | ||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||
出版國/地區 | IRELAND | ||||||||||||||||||||||||||
發行頻率 | 月2回刊行 | ||||||||||||||||||||||||||
創刊年 | 1979 | ||||||||||||||||||||||||||
每年文章數 | 1281每年文章數趨勢 | ||||||||||||||||||||||||||
黃金OA百分比 | 8.87% | ||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0378-8741%5BISSN%5D | ||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 3.0 month(s) 來自Elsevier的數據: Average 9.9 Week(s) | ||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 55.45% | ||||||||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 3 Week(s) | ||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[JOURNAL OF ETHNOPHARMACOLOGY] 的評論 | 撰寫評論 |
作者: 阿标 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-06-14 19:15:16 評論於 It's been three weeks, and still in the same situation. ![]() ![]() |
作者: 量子薄荷 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2025-06-12 10:52:14 評論於 Submitted, the editor returned three days later asking for some details to be modified and for the word count to be reduced. After making changes, it was resubmitted three days later and rejected the next day for not meeting the 5 principles. The specific reasons were not provided, and it is frustrating that they did not notice this the first time and still required me to revise the manuscript again. ![]() ![]() |
作者: wmpwisteria11 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-06-06 10:28:10 評論於 On April 15, 2025, the revised manuscript was submitted. The first two reviewers had no major comments, but the third reviewer had some minor suggestions. However, after the revision, the third reviewer has not reviewed the manuscript and the status remained "with editor" until May 22, 2025. Now, it is unclear what the situation is, and the author is hesitant to ask. ![]() ![]() |
作者: lijiaxinheilongjiang 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-06-06 08:55:42 評論於 Did you give a reason? ![]() ![]() |
作者: 天使 領域: 医学 審稿時間: 5.0 month(s) 結果: 拒稿 撰寫評論 |
2025-06-03 15:09:06 評論於 I have been rejected twice. ![]() ![]() |
作者: organoid 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2025-05-26 14:18:12 評論於 The Chinese medicine compound formula has been rejected for submission because the journal does not accept studies on single doses. However, my compound formula is a commercial product with a dose converted from clinical dosage. I don't know if I can appeal and resubmit it. ![]() ![]() |
作者: 小范范范范 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-05-23 08:50:42 評論於 Please translate the following paragraph into English: 接接接 "Connect, connect, connect" ![]() ![]() |
作者: 科研后知后觉 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-05-08 16:06:02 評論於 I conducted pharmacological research on the monomeric components isolated from the compound traditional Chinese medicine in my continuing research. It went quite smoothly this time, with submission on February 25, revision on March 25, another revision on April 11, and acceptance on April 22. ![]() ![]() |
作者: 游剑敏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-05-04 15:02:05 評論於 Please translate the following paragraph into English: 11 ![]() ![]() |
作者: HU 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-04-11 13:50:57 評論於 It's been two weeks, and it's still "WE". ![]() ![]() |
作者: xhd123 領域: 医学 審稿時間: 5.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-03-20 15:55:33 評論於 I am majoring in Chinese medicine, focusing on single herb research. Submitted on October 22, 2024 Under Review on November 24, 2024 First Revision on December 15, 2024 Returned on December 26, 2024 Under Review again on December 29, 2024 (One reviewer left, editor invited 9 new reviewers, causing delays) Second Revision on February 6, 2025 Returned on February 17, 2025 Under Review again on February 19, 2025 (One reviewer accepted, one hasn't reviewed yet) Accepted on March 15, 2025 (Took almost half a year, both reviewers left during the process, causing delays) Notes: 1. Clearly state the composition of Chinese herbs, HPLC, MS, etc. 2. Herbs should be stored in a herbarium with a specific number. 3. Research on herbs should be related to ethnopharmacology, for example, if historically the herb was used for anti-inflammatory purposes, your research should focus on that area. 4. Dosage is important, there should be dosage selection experiments or a basis for the dosage, such as the dosage in the Chinese Pharmacopoeia combined with the formula for converting dosages for mice. These are the important details, the rest are formatting and image clarity issues. First SCI publication, happy, hahaha. ![]() ![]() |
作者: atleast340 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-03-20 14:56:04 評論於 I submitted it at the end of last year, and it's been over 3 months and it's still with the editor. I inquired after a month and a half, and received a vague response. Everyone can make their own judgment. ![]() ![]() |
作者: 地狱针灸 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-03-11 09:27:14 評論於 I give up, I have been submitting for two weeks, but the editor has not responded. ![]() ![]() |
作者: Fire123 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-02-13 15:40:26 評論於 Submitted on December 17, 2024 Revised once in between Accepted on January 24, 2025 Online on January 25, 2025 Thank you, journal ??? ![]() ![]() |
作者: 長安 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-02-01 09:19:32 評論於 Employed after rework on January 25, 1931. ![]() ![]() |
作者: yu98 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-01-04 17:42:06 評論於 Hello friend, I have been returned twice with the same issue, stating that I did not list the abbreviation table and specimen number. However, I have already listed them in the manuscript and still got returned. Is there a specific way to submit these two things separately? ![]() ![]() |
作者: 長安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-12-23 09:17:53 評論於 Submitted on 24.11.13, received RRC on 24.12.10. The review process was quite fast, but it has been over ten days since RRC and I don't know what's going on... ![]() ![]() |
作者: pipihao 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-12-06 21:28:09 評論於 How is everything going on, teacher? ![]() ![]() |
作者: 巅66球 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-12-06 17:19:56 評論於 There is no need to provide full WB film. ![]() ![]() |
作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-11-30 14:30:15 評論於 How is it going? Is there a conclusion yet? ![]() ![]() |
作者: hbzyydx 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-11-15 13:06:15 評論於 Timeline: April 27, 2024, first submission; June 19, 2024, three reviewers, two positive, one neutral, rejected; September 19, 2024, second submission; November 2, 2024, three reviewers, including two from the previous submission, two acceptances, new reviewer minor revisions; November 3, 2024, submit revised manuscript; November 14, 2024, all three reviewers indicate acceptance. ![]() ![]() |
作者: hbzyydx 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-11-15 12:59:37 評論於 After revising the submission, although two of the three reviewers had no issues and one suggested minor revisions, the editor still sent it for review...frustrating. The same three reviewers were involved again. The first two reiterated that there were no problems, and the third reviewer confirmed that the necessary revisions had been made. Only then did the editor choose to accept the submission. Teacher Ge still remains cautious, hoping that our relationship has come to an end, and in the future, we must submit our work directly to foreign editors! ![]() ![]() |
作者: 面向内啡肽 領域: 医学 審稿時間: 2.0 month(s) 結果: 直接被接受 撰寫評論 |
2024-11-13 16:50:36 評論於 The word count is exceeded... continue writing. So I resubmitted on September 21st, and it was transferred to "with editor" in 4 days (not the same editor as last time, so I don't know if I would have been rejected directly, haha). It showed "Under reviewer" on September 30th, and 7 reviewers were invited, 5 accepted. By October 13th, 5 reviewers had finished reviewing and I was asked to revise (due on November 3rd) (1 reviewer only pointed out a small writing issue, while the other 4 provided 5-7 questions each, and I made some changes to the abstract and figures). The revised manuscript was sent to 5 reviewers on October 25th, and only 4 accepted (probably the other one didn't find any issues). The second round of reviews was completed on November 4th, with one reviewer providing some additional comments (the other reviewers had no more issues, it was more of a personal preference of the reviewer, otherwise the paper might have been accepted at this stage). I made the second revision on November 5th, addressing the comments of this reviewer and resubmitted on November 6th. The reviewer had no more issues by November 10th, and the editor accepted the paper and sent it to production. Elsevier sent the proof on November 11th, and I submitted the final version on November 13th. It was a bumpy road, but the review process of this journal was relatively fast, and I was lucky to have it accepted before my defense. ![]() ![]() |
作者: 面向内啡肽 領域: 医学 審稿時間: 2.0 month(s) 結果: 直接被接受 撰寫評論 |
2024-11-13 16:49:43 評論於 Originally, the submission was probably on 8.20, there was a little misunderstanding, mainly because when I first submitted it, it was returned for revision due to the issue of repetition rate (35%). After 5 days of revision, I re-uploaded it on (8.26) (around 29%, it was really frustrating to revise so much, this plagiarism check is a bit crazy...), but after I re-uploaded it, it took me 2 more days to continue to reduce the similarity (worried that the previous reduction was not enough, reduced to 21%). At that time, I sent an email wanting to contact the editor to replace the uploaded manuscript (the status was still Submitted to Journal at that time), but there was no response. About 10 days later, the editor approved it and sent it for review (Under Review around 9.6), showing that 5 reviewers were sent, 3 accepted, 1 completed the review. It seemed to be going well, but when I checked on 9.20, it suddenly showed Completed - Withdrawn on 9.17, which left me confused. I checked my email and realized that the previous email requesting a change of manuscript was causing the confusion. It turned out that this email was received by the Elsevier administrator (I sent the email from the magazine submission interface, I don't know how it happened, sigh), and the Elsevier staff kept contacting the magazine editor saying that I wanted to change/withdraw the manuscript, resulting in it being withdrawn halfway through the review process... ![]() ![]() |
作者: 花莽子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-11-09 08:23:17 評論於 Is there any news? ![]() ![]() |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us